Bruce is the Principal of Galton Consulting, LLC, a biopharmaceutical and healthcare consulting practice. He has over 20 years of experience as President and CEO of development stage biotechnology companies and manufacturers, both publicly and privately held. Bruce has negotiated licenses and sales agreements, has in-licensed technologies and sponsored research projects with major universities across North America and has participated in the acquisition and divestiture of product lines and companies. He has also helped to raise tens of millions of dollars in equity financing. As a consultant, he has been a project manager for preclinical toxicology, drug metabolism, and pharmacokinetic IND enabling studies, participated in technology portfolio assessments and provided development prioritization plans, negotiated IP licenses, drafted business plans, assisted clients with VC networking and has supported client due diligence for partnering negotiations. Bruce is also co-inventor on several biotechnology patents and applications.